Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferrous iron (Fe2+) is the divalent oxidation state of iron and a fundamental micronutrient essential for human physiology, primarily serving as the central functional unit of hemoglobin and myoglobin for oxygen transport and storage. In biological systems, Fe2+ exists within a tightly regulated labile iron pool where it acts as a critical cofactor for enzymes involved in DNA synthesis, mitochondrial electron transport, and the citric acid cycle. However, Fe2+ in solution is highly reactive and can participate in the Fenton reaction, which generates hydroxyl radicals that cause significant oxidative stress and cellular damage. Pathological imbalances in Fe2+ levels lead to conditions such as iron deficiency anemia or iron overload disorders like hereditary hemochromatosis and transfusion-dependent thalassemia. Pharmacological management involves the administration of ferrous salts to treat deficiency or the use of iron chelators, such as deferoxamine and deferasirox, which bind Fe2+ to prevent toxicity and facilitate its excretion. Monitoring Fe2+ status through biomarkers like serum ferritin and transferrin saturation is essential for maintaining systemic iron homeostasis and preventing long-term organ damage. NIH Office of Dietary Supplements (2023). Iron Fact Sheet. Cell 117(3):285-97. Winterbourn (1995). Toxicol Lett 82-83:969-74. J Res Med Sci 19(2):164-74. Int J Hematol Oncol Stem Cell Res 10(4):239-247.
Ferrous iron serves as a substrate for heme synthesis in supplementation therapy or is sequestered by chelating agents to prevent oxidative damage and facilitate excretion in cases of iron overload.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferrous iron (Fe2+) (Fe2+).